Searched for
GUO GUANGCHANG
Kedaara, TA Associates vie for minority stake in Sagent PharmaKedaara Capital and TA Associates are in talks to acquire a significant minority stake in Sagent Pharma, valued at $500-600 million. Invest...- Fosun is said to plan block deals to pare stake in Gland PharmaThe listed arm of billionaire Guo Guangchang’s Fosun International Ltd. holds about 58% of Gland Pharma, which has a market value 303 billi...
- Another Chinese business head goes missing, copper tycoon believed to be detained by policeExecutives at Maike Metals International Co., one of China's largest copper trading houses, have lost contact with the company's founder, H...
- Blackstone acquires diamond certification co IGI for $570 mnBlackstone on Sunday said that it has acquired International Gemological Institute (IGI) from China's Fosun and Roland Lorie, part of the f...
- Blackstone set to buy diamond grading company IGI for up to $550 millionPE to buy IGI from Fosun, founders, small shareholders in a deal likely to be signed this weekend.
- Chinese business tycoons, executives who disappeared from public viewChina Renaissance said late on Thursday it had been unable to contact founder Bao Fan, a disclosure that sent its stock down as much as 50%...
- Gland says not heard from its promoter Fosun about the potential saleThe debt-laden Chinese conglomerate Fosun controlled by billionaire entrepreneur Guo Guangchang has been looking to sell non-core assets, t...
- Fosun Said to Mull Sale of India’s $3.6 Billion Gland PharmaA sale would help Gland’s Chinese owner raise cash as the once-acquisitive group seeks to shore up its balance sheet. Fosun International h...
- China’s Fosun pulls out of $300 million healthcare deals amid negative sentimentAccording to sources, both deals were at an advanced stage, and Fosun had formally proposed terms for acquiring a stake in the companies, o...
- China still has a treasure chest of overseas real estate to sellReal estate asset sales by Chinese companies have surged to $12.3 billion since January.
- Hong Kong's world-beating IPO market starts to show cracksA parenting website part-owned by Alibaba Group on Tuesday delayed the launch of its HK IPO.
- Jack Ma's crazy rich Asian odyssey has a timely endTime and time again, Chinese billionaires on lists of the super-wealthy have been cut down to size.
- Fosun targets Fortis: A white knight or a dark horse?Often known as China's Warren Buffett, Guo Guangchang prefers to be his student instead. His mysterious disappearance last year raised many...
- Nitesh Estates soars 20% in early trade; here’s whyThe scrip jumped 19.95 per cent to its fresh 52-week high of Rs 15.93 on Thursday.
- Doklam effect? India said to block Fosun's $1.3 billion Gland purchaseThe companies haven’t been formally notified yet of the move, the people said, asking not to be identified because the information is priva...
- Two Chinese companies hit roadblock with Indian investmentsIn June 2016, India allowed automatic approval for foreign investments up to 74% in pharmaceutical manufacturing.
- China's Shanghai Fosun to acquire 86% stake in Gland Pharma for $1.4 billionShanghai Fosun will acquire the shares held by Gland Pharma founders Ravi Penmetsa and his family and PE giant KKR.
- China's Fosun to buy KKR backed Gland Pharma for $1.4 billionFosun has agreed to acquire 96 percent stake, which includes shares held by founders of Gland Pharma Ravi Penmetsa and family and private e...
- Fosun leads the race to buy Gland Pharma with $1.27 billion bidComing from behind in a closely fought race that saw US giant Baxter and private equity fund Advent make firm offers early May, Hong Kong-l...
- China stocks slump as report of missing billionaire Guo Guangchang compounds woesThe Hang Seng China Enterprises Index retreated for a seventh day, led by industrial and power companies.
Load More
